212 related articles for article (PubMed ID: 31825847)
1. A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.
Lawrenson K; Fonseca MAS; Liu AY; Segato Dezem F; Lee JM; Lin X; Corona RI; Abbasi F; Vavra KC; Dinh HQ; Gill NK; Seo JH; Coetzee S; Lin YG; Pejovic T; Mhawech-Fauceglia P; Rowat AC; Drapkin R; Karlan BY; Hazelett DJ; Freedman ML; Gayther SA; Noushmehr H
Cell Rep; 2019 Dec; 29(11):3726-3735.e4. PubMed ID: 31825847
[TBL] [Abstract][Full Text] [Related]
2. PAX8 expression in ovarian surface epithelial cells.
Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.
Dinh HQ; Lin X; Abbasi F; Nameki R; Haro M; Olingy CE; Chang H; Hernandez L; Gayther SA; Wright KN; Aspuria PJ; Karlan BY; Corona RI; Li A; Rimel BJ; Siedhoff MT; Medeiros F; Lawrenson K
Cell Rep; 2021 Apr; 35(2):108978. PubMed ID: 33852846
[TBL] [Abstract][Full Text] [Related]
4. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
Karst AM; Levanon K; Drapkin R
Proc Natl Acad Sci U S A; 2011 May; 108(18):7547-52. PubMed ID: 21502498
[TBL] [Abstract][Full Text] [Related]
5. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Coetzee SG; Shen HC; Hazelett DJ; Lawrenson K; Kuchenbaecker K; Tyrer J; Rhie SK; Levanon K; Karst A; Drapkin R; Ramus SJ; ; Couch FJ; Offit K; Chenevix-Trench G; Monteiro AN; Antoniou A; Freedman M; Coetzee GA; Pharoah PD; Noushmehr H; Gayther SA;
Hum Mol Genet; 2015 Jul; 24(13):3595-607. PubMed ID: 25804953
[TBL] [Abstract][Full Text] [Related]
6. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.
Hua G; Lv X; He C; Remmenga SW; Rodabough KJ; Dong J; Yang L; Lele SM; Yang P; Zhou J; Karst A; Drapkin RI; Davis JS; Wang C
Oncogene; 2016 Apr; 35(17):2247-65. PubMed ID: 26364602
[TBL] [Abstract][Full Text] [Related]
7. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
8. In vitro three-dimensional modeling of fallopian tube secretory epithelial cells.
Lawrenson K; Notaridou M; Lee N; Benjamin E; Jacobs IJ; Jones C; Gayther SA
BMC Cell Biol; 2013 Sep; 14():43. PubMed ID: 24070420
[TBL] [Abstract][Full Text] [Related]
9. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
10. Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.
Elias KM; Emori MM; Westerling T; Long H; Budina-Kolomets A; Li F; MacDuffie E; Davis MR; Holman A; Lawney B; Freedman ML; Quackenbush J; Brown M; Drapkin R
JCI Insight; 2016 Aug; 1(13):. PubMed ID: 27617304
[TBL] [Abstract][Full Text] [Related]
11. Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
Chen F; Gaitskell K; Garcia MJ; Albukhari A; Tsaltas J; Ahmed AA
BJOG; 2017 May; 124(6):872-878. PubMed ID: 28218502
[TBL] [Abstract][Full Text] [Related]
12. Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.
Chhabra R; Rockfield S; Guergues J; Nadeau OW; Hill R; Stevens SM; Nanjundan M
Sci Rep; 2021 Mar; 11(1):6270. PubMed ID: 33737539
[TBL] [Abstract][Full Text] [Related]
13. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
Nakamura K; Reid BM; Chen A; Chen Z; Goode EL; Permuth JB; Teer JK; Tyrer J; Yu X; Kanetsky PA; Pharoah PD; Gayther SA; Sellers TA; Lawrenson K; Karreth FA
Am J Hum Genet; 2022 Jan; 109(1):116-135. PubMed ID: 34965383
[TBL] [Abstract][Full Text] [Related]
15. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
16. IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE.
Cho KR
Trans Am Clin Climatol Assoc; 2018; 129():40-47. PubMed ID: 30166697
[TBL] [Abstract][Full Text] [Related]
17. NF-κB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium.
Brand H; Barnabas GD; Sapoznik S; Bahar-Shany K; Pozniak Y; Yung Y; Hourvitz A; Geiger T; Jacob-Hirsch J; Levanon K
Carcinogenesis; 2020 Dec; 41(12):1703-1712. PubMed ID: 32614381
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
[TBL] [Abstract][Full Text] [Related]
19. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium.
Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR
J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879
[TBL] [Abstract][Full Text] [Related]
20. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
